Compare TAK & FERG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAK | FERG |
|---|---|---|
| Founded | 1781 | 1887 |
| Country | Japan | United States |
| Employees | 47455 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Miscellaneous |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.4B | 46.3B |
| IPO Year | N/A | 2024 |
| Metric | TAK | FERG |
|---|---|---|
| Price | $16.98 | $222.06 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $268.54 |
| AVG Volume (30 Days) | ★ 2.9M | 1.3M |
| Earning Date | 05-13-2026 | 06-02-2026 |
| Dividend Yield | ★ 3.24% | 1.39% |
| EPS Growth | N/A | ★ 9.26 |
| EPS | N/A | ★ 2.13 |
| Revenue | N/A | ★ $30,762,000,000.00 |
| Revenue This Year | $0.16 | $7.98 |
| Revenue Next Year | $1.22 | $5.86 |
| P/E Ratio | ★ $41.25 | $107.45 |
| Revenue Growth | N/A | ★ 3.80 |
| 52 Week Low | $12.99 | $207.64 |
| 52 Week High | $18.90 | $271.64 |
| Indicator | TAK | FERG |
|---|---|---|
| Relative Strength Index (RSI) | 67.74 | 39.01 |
| Support Level | $15.88 | $219.51 |
| Resistance Level | $18.86 | $232.35 |
| Average True Range (ATR) | 0.23 | 6.28 |
| MACD | 0.18 | -0.92 |
| Stochastic Oscillator | 90.76 | 5.49 |
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
Ferguson distributes plumbing and HVAC products to North American repair, maintenance, and improvement, new construction, and civil infrastructure markets. It serves over 1 million customers and sources products from 37,000 suppliers. Ferguson engages customers through approximately 1,700 North American branches, over the phone, online, and in residential showrooms. The firm sold its UK business in 2021 and is now solely focused on the North American market.